PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2019-12-02

Date Title Company
02-Dec-2019 QBiotics Announces First Patient Dosed in its Phase I/II Clinical Trial of Tigilanol Tiglate for Head and Neck Cancer QBiotics Group Limited
02-Dec-2019 Ardelyx to Host Conference Call on December 3 to Review Results from the Pivotal Phase 3 PHREEDOM Study Ardelyx
02-Dec-2019 Amgen Announces Data Being Presented At ASH 2019 Amgen
02-Dec-2019 Prime Therapeutics Welcomes Christine Bent as New Chief Operating Officer Prime Therapeutics LLC
02-Dec-2019 Southwest Transplant Alliance Expands Automated Electronic Referral System to Save More Lives Southwest Transplant Alliance
02-Dec-2019 Confo Therapeutics reports grant of two key patents for ConfoBodies™ Confo Therapeutics
02-Dec-2019 ASLAN PHARMACEUTICALS REPORTS POSITIVE PRELIMINARY DATA FROM PROOF-OF-CONCEPT STUDY FOR ASLAN004 TARGETING ATOPIC DERMATITIS ASLAN Pharmaceuticals
02-Dec-2019 Destiny Pharma to present at the Partnerships to Tackle the Global Challenge of AMR, UK-China AMR Workshop Destiny Pharma plc
02-Dec-2019 Cambridge Innovation Capital has attracted £1 billion of investment into Cambridge companies Cambridge Innovation Capital
02-Dec-2019 Lewis Cameron, Former Head of Global Clinical Development at Covance, Appointed as Chief Operating Officer Ergomed plc
02-Dec-2019 ABPI appoints Dr Richard Torbett as new Chief Executive The Association of the British Pharmaceutical Industry (ABPI)
02-Dec-2019 Elucid Health achieves 100% robustness in ongoing trials of their Pill Connect smart pill bottle that could help improve adherence to medications Elucid Health
02-Dec-2019 NICE EXPANDS RECOMMENDATION FOR LYNPARZATM (OLAPARIB) TABLETS FOR WOMEN WITH RELAPSED, BRCA-MUTATED, ADVANCED OVARIAN CANCER[I] AstraZeneca
02-Dec-2019 TrialScope Launches Clinical Trials Website for EMD Serono TrialScope
02-Dec-2019 BioMed X Reaches Milestone in Respiratory Disease Research Collaboration with Boehringer Ingelheim BioMed X Innovation Center
02-Dec-2019 Akari Therapeutics Announces Pivotal Phase III Trial Design of Nomacopan in Pediatric Hematopoietic Stem Cell Transplant-Related Thrombotic Microangiopathy (HSCT-TMA), Following FDA Meeting Akari Therapeutics
02-Dec-2019 iPatientAxis Announces Early Participation in Newly Launched AWS Data Exchange iPatientAxis
02-Dec-2019 Bayer selects Pharmaron as partner organization Bayer
02-Dec-2019 European CNS specialist Neuraxpharm expands Southern European presence with expansion into Portugal Neuraxpharm Group (Neuraxpharm)
02-Dec-2019 One Nucleus announces finalists of the BioNewsRound Award One Nucleus